Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a highly immunogenic tumor. The purpose of the present study was to establish a novel immunotype for different immune infiltration and overall survival (OS) of patients with ccRCC. METHODS: Based on the Cancer Genome Atlas Project (TCGA) databas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Deshui, Zhang, Xuanzhi, Gao, Lixia, Qian, Subo, Tang, Hong, Shao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552763/
https://www.ncbi.nlm.nih.gov/pubmed/36237315
http://dx.doi.org/10.3389/fonc.2022.924072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552763/
https://www.ncbi.nlm.nih.gov/pubmed/36237315
http://dx.doi.org/10.3389/fonc.2022.924072

Ejemplares similares